| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |